BioSpace News Archive

Policy

Chipscreen’s New Drug Candidate CS32582 Capsules Approved for Clinical Treatment of Psoriasis

Shenzhen Chipscreen Biosciences Co., Ltd. received the “Drug Clinical Trial Approval Notice” issued by the National Medical Products Administration through its wholly-owned subsidiary, Chengdu Chipscreen Pharmaceutical Co., Ltd.

November 2, 2023
·
4 min read
Philips and County Durham and Darlington NHS Foundation Trust collaborate on a sustainability blueprint to reduce carbon emissions and waste

Royal Philips, a global leader in health technology and County Durham and Darlington NHS Foundation Trust, one of the largest integrated care providers in England, announced the results of a comprehensive 360 sustainability analysis.

November 2, 2023
·
5 min read
BioForest

Renaissance BioScience and Certis Belchim enter partnership for innovative biopesticide development

Renaissance BioScience is pleased to announce that it has signed a joint development agreement with Certis Belchim, a global leader in the development of crop-protecting biocontrol agents that combat agricultural pests.

November 2, 2023
·
3 min read
Pharm Country

Cambrex Announces Sale of Drug Product Business Unit

Cambrex, a leading global contract development and manufacturing organization, has completed the sale of its Drug Product Business Unit to Wilmington, Delaware based Noramco.

November 2, 2023
·
1 min read
Business

Dentsply Sirona Reports Third Quarter 2023 Results

DENTSPLY SIRONA Inc. announced its financial results for the third quarter of 2023.

November 2, 2023
·
22 min read
Business

The Cigna Group Reports Strong Third Quarter 2023 Results, Raises 2023 Adjusted EPS, Revenue, and Cash Flow Outlook

Global health company The Cigna Group reported strong third quarter results reflecting revenue and earnings growth across its diversified portfolio of businesses.

November 2, 2023
·
27 min read
Business

Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity

Lilly defines New Products as select products launched since 2022, which currently consist of Jaypirca, Mounjaro and Omvoh.

November 2, 2023
·
24 min read
Business

Karuna Therapeutics Reports Third Quarter 2023 Financial Results and Provides General Business Updates

Karuna Therapeutics, Inc., a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, announced financial results for the third quarter of 2023 and provided a general business update.

November 2, 2023
·
10 min read
Business

Omnicell Announces Third Quarter 2023 Results; Updates Fiscal Year 2023 Guidance and Announces Reduction in Force

Omnicell, Inc. today announced results for its third quarter ended September 30, 2023.

November 2, 2023
·
36 min read
Biotech Beach

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Conduit Pharmaceuticals Inc. today announced that its CEO, Dr. David Tapolczay, and its CFO, Adam Sragovicz, will be attending the 14th Annual Jefferies London Healthcare Conference, taking place from Tuesday, November 14 to Thursday, November 16.

November 2, 2023
·
3 min read